230 related articles for article (PubMed ID: 23272150)
1. Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients.
Park HY; Jun CD; Jeon SJ; Choi SS; Kim HR; Choi DB; Kwak S; Lee HS; Cheong JS; So HS; Lee YJ; Park DS
PLoS One; 2012; 7(12):e51722. PubMed ID: 23272150
[TBL] [Abstract][Full Text] [Related]
2. Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease.
Xu X; Ma H; Xu J; Huang H; Wu X; Xiong Y; Zhan H; Huang F
Bosn J Basic Med Sci; 2014 Aug; 14(3):120-4. PubMed ID: 25172968
[TBL] [Abstract][Full Text] [Related]
3. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
Jiang YX; Zhang GH; Wang ZM; Yang H
Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
[TBL] [Abstract][Full Text] [Related]
4. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke.
Tu WJ; Zhao SJ; Liu TG; Yang DG; Chen H
Neurol Res; 2013 Nov; 35(9):912-21. PubMed ID: 23816540
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
[TBL] [Abstract][Full Text] [Related]
6. The association between serum YKL-40 levels, mean platelet volume, and c-reactive protein in patients with cellulitis.
Erturk A; Cure E; Cure MC; Parlak E; Kurt A; Ogullar S
Indian J Med Microbiol; 2015 Feb; 33 Suppl():61-6. PubMed ID: 25657159
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
Ridker PM; Chasman DI; Rose L; Loscalzo J; Elias JA
J Am Heart Assoc; 2014 Jun; 3(3):e000897. PubMed ID: 24958781
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
Pei Q; Sang WF; Zhao XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
[TBL] [Abstract][Full Text] [Related]
10. Significant association of elevated concentration of plasma YKL-40 with disease severity in patients with pelvic inflammatory disease.
Lee SH; Lin CY; Wang PH; Han CP; Yang SF; Chang JT; Lee MC; Lin LY; Lee MS
J Clin Lab Anal; 2012 May; 26(3):136-42. PubMed ID: 22628227
[TBL] [Abstract][Full Text] [Related]
11. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population.
Allin KH; Bojesen SE; Johansen JS; Nordestgaard BG
Br J Cancer; 2012 Jan; 106(1):199-205. PubMed ID: 22095223
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma YKL-40 levels and ischemic stroke in the general population.
Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG
Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582
[TBL] [Abstract][Full Text] [Related]
14. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.
Li W; Yu Z; Jiang C
Lab Med; 2014; 45(3):220-5. PubMed ID: 25051073
[TBL] [Abstract][Full Text] [Related]
15. Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke.
Rathcke CN; Thomsen SB; Linneberg A; Vestergaard H
PLoS One; 2012; 7(8):e43498. PubMed ID: 22937056
[TBL] [Abstract][Full Text] [Related]
16. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.
Conrozier T; Carlier MC; Mathieu P; Colson F; Debard AL; Richard S; Favret H; Bienvenu J; Vignon E
Ann Rheum Dis; 2000 Oct; 59(10):828-31. PubMed ID: 11005786
[TBL] [Abstract][Full Text] [Related]
18. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
[TBL] [Abstract][Full Text] [Related]
19. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke.
Qi AQ; Li Y; Liu Q; Si JZ; Tang XM; Zhang ZQ; Qi QD; Chen WB
Free Radic Biol Med; 2015 Mar; 80():129-35. PubMed ID: 25555670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]